HYBRID MRNA TECHNOLOGY
DEAD

Serial Number

87152206

Owner

PhaseRx, Inc.

Attorney

Louis C. Cullman

Filing Date

Aug 26, 2016

Add to watchlist:

No watchlists yet
View on USPTO

HYBRID MRNA TECHNOLOGY Trademark

Serial Number: 87152206

HYBRID MRNA TECHNOLOGY is a trademark filed by PhaseRx, Inc. on August 26, 2016. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

PhaseRx, Inc. (16 trademarks)

410 W. Harrison Street, Suite 300
Seattle, WA 98119

Entity Type: 03

Trademark Details

Filing Date

August 26, 2016

Registration Date

Not Registered

Goods & Services

Pharmaceutical preparations, namely, a drug delivery system composed of polymers and lipid nanoparticles delivered as integral components of drugs used for the delivery of macromolecules to human tissue

Medical and scientific research in the fields of pharmaceuticals, biologics, drug delivery and medical therapeutics for others; product research and development for others in the fields of pharmaceutical formulations of macromolecules, macromolecular pharmaceutical products, macromolecular therapeutics, and delivery of macromolecular therapeutics

Filing History

ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Feb 6, 2018 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Feb 6, 2018 ABN2
NOTIFICATION OF FINAL REFUSAL EMAILED
Jul 11, 2017 GNFN
FINAL REFUSAL E-MAILED
Jul 11, 2017 GNFR
FINAL REFUSAL WRITTEN
Jul 11, 2017 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 9, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 9, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 9, 2017 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 11, 2016 GNRN
NON-FINAL ACTION E-MAILED
Dec 11, 2016 GNRT
NON-FINAL ACTION WRITTEN
Dec 11, 2016 CNRT
ASSIGNED TO EXAMINER
Dec 6, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 1, 2016 NWOS
NEW APPLICATION ENTERED
Aug 30, 2016 NWAP